Insulet (PODD) Amortization of Deferred Charges (2010 - 2026)
Insulet's (PODD) quarterly Amortization of Deferred Charges came in at $700000.0 in Q2 2026, up 75.0% on a YoY basis from $400000.0 in Q2 2025, and little changed quarter-over-quarter from $700000.0 in Q1 2026.
Analysis
Insulet (PODD) Amortization of Deferred Charges (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Amortization of Deferred Charges for 17 consecutive years, with $700000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Amortization of Deferred Charges rose 75.0% year-over-year to $700000.0; the trailing twelve-month figure through Jun 2026 stood at $3.9 million (down 30.36% YoY), and the FY2025 full-year result was $6.2 million, down 15.07% from the prior year.
- Amortization of Deferred Charges steadied at $700000.0 in Q2 2026 per PODD's latest filing, from $700000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $2.5 million in Q1 2025 and bottomed at $400000.0 in Q2 2025.
- Historically, Amortization of Deferred Charges has averaged $1.3 million across 5 years, with a median of $1.2 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Amortization of Deferred Charges tumbled 87.29% in 2022, then jumped 112.5% in 2025.
- Over 5 years, Amortization of Deferred Charges stood at $1.5 million in 2022, then soared by 40.0% to $2.1 million in 2023, then decreased by 9.52% to $1.9 million in 2024, then slumped by 57.89% to $800000.0 in 2025, then slipped by 12.5% to $700000.0 in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $700000.0, $700000.0, and $800000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 700,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 1.70 Mn |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 800,000.00 |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 2.10 Mn |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 8.30 Mn |
| Sep 30, 2021 | 900,000.00 |